-
1
-
-
0016775711
-
A review on the chemical and pharmacological aspects of genus Berberis
-
Ikram M: A review on the chemical and pharmacological aspects of genus Berberis. Planta Med 28: 353-358, 1975.
-
(1975)
Planta Med
, vol.28
, pp. 353-358
-
-
Ikram, M.1
-
2
-
-
0035008292
-
Inhibition of chemical carcinogenesis by berberine in rats and mice
-
DOI 10.1211/0022357011775901
-
Anis KV, Rajeshkumar NV and Kuttan R: Inhibition of chemical carcinogenesis by berberine in rats and mice. J Pharm Pharmacol 53: 763-768, 2001. (Pubitemid 32457828)
-
(2001)
Journal of Pharmacy and Pharmacology
, vol.53
, Issue.5
, pp. 763-768
-
-
Anis, K.V.1
Rajeshkumar, N.V.2
Kuttan, R.3
-
3
-
-
0028301101
-
Flow cytometric analysis of the effect of berberine on the expression of glucocorticoid receptors in human hepatoma HepG2 cells
-
Chi CW, Chang YF, Chao TW, et al.: Flow cytometric analysis of the effect of berberine on the expression of glucocorticoid receptors in human hepatoma HepG2 cells. Life Sci 54: 2099-2107, 1994.
-
(1994)
Life Sci
, vol.54
, pp. 2099-2107
-
-
Chi, C.W.1
Chang, Y.F.2
Chao, T.W.3
-
4
-
-
0028814733
-
Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells
-
Kuo CL, Chou CC and Yung BY: Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells. Cancer Lett 93: 193-200, 1995.
-
(1995)
Cancer Lett
, vol.93
, pp. 193-200
-
-
Kuo, C.L.1
Chou, C.C.2
Yung, B.Y.3
-
5
-
-
73349135948
-
Silibinin suppresses TNF-alpha-induced MMP-9 expression in gastric cancer cells through inhibition of the MAPK pathway
-
Kim S, Choi MG, Lee HS, et al.: Silibinin suppresses TNF-alpha-induced MMP-9 expression in gastric cancer cells through inhibition of the MAPK pathway. Molecules 14: 4300-4311, 2009.
-
(2009)
Molecules
, vol.14
, pp. 4300-4311
-
-
Kim, S.1
Choi, M.G.2
Lee, H.S.3
-
6
-
-
41949120203
-
Berberine inhibits TPA-induced MMP-9 and IL-6 expression in normal human keratinocytes
-
DOI 10.1016/j.phymed.2007.09.011, PII S0944711307002334
-
Kim S, Kim Y, Kim JE, Cho KH and Chung JH: Berberine inhibits TPA-induced MMP-9 and IL-6 expression in normal human keratinocytes. Phytomedicine 15: 340-347, 2008. (Pubitemid 351508395)
-
(2008)
Phytomedicine
, vol.15
, Issue.5
, pp. 340-347
-
-
Kim, S.1
Kim, Y.2
Kim, J.E.3
Cho, K.H.4
Chung, J.H.5
-
7
-
-
58149252230
-
Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells
-
Kim S, Choi JH, Kim JB, et al.: Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells. Molecules 13: 2975-2985, 2008.
-
(2008)
Molecules
, vol.13
, pp. 2975-2985
-
-
Kim, S.1
Choi, J.H.2
Kim, J.B.3
-
8
-
-
48649104437
-
Berberine prevents UV-induced MMP-1 and reduction of type I procollagen expression in human dermal fibroblasts
-
Kim S and Chung JH: Berberine prevents UV-induced MMP-1 and reduction of type I procollagen expression in human dermal fibroblasts. Phytomedicine 15: 749-753, 2008.
-
(2008)
Phytomedicine
, vol.15
, pp. 749-753
-
-
Kim, S.1
Chung, J.H.2
-
9
-
-
0035835820
-
Regulation of p53 function
-
DOI 10.1006/excr.2000.5141
-
Woods DB and Vousden KH: Regulation of p53 function. Exp Cell Res 264: 56-66, 2001. (Pubitemid 32989081)
-
(2001)
Experimental Cell Research
, vol.264
, Issue.1
, pp. 56-66
-
-
Woods, D.B.1
Vousden, K.H.2
-
10
-
-
33745115304
-
p53 and breast cancer, an update
-
DOI 10.1677/erc.1.01172
-
Lacroix M, Toillon RA and Leclercq G: p53 and breast cancer, an update. Endocr Relat Cancer 13: 293-325, 2006. (Pubitemid 43886660)
-
(2006)
Endocrine-Related Cancer
, vol.13
, Issue.2
, pp. 293-325
-
-
Lacroix, M.1
Toillon, R.-A.2
Leclercq, G.3
-
11
-
-
0033959744
-
MDM2 - Master regulator of the p53 tumor suppressor protein
-
DOI 10.1016/S0378-1119(99)00487-4, PII S0378111999004874
-
Momand J, Wu HH and Dasgupta G: MDM2-master regulator of the p53 tumor suppressor protein. Gene 242: 15-29, 2000. (Pubitemid 30064488)
-
(2000)
Gene
, vol.242
, Issue.1-2
, pp. 15-29
-
-
Momand, J.1
Wu, H.-H.2
Dasgupta, G.3
-
13
-
-
0030886015
-
Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53
-
DOI 10.1073/pnas.94.18.9648
-
Sugrue MM, Shin DY, Lee SW and Aaronson SA: Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc Natl Acad Sci USA 94: 9648-9653, 1997. (Pubitemid 27408116)
-
(1997)
Proceedings of the National Academy of Sciences of the United States of America
, vol.94
, Issue.18
, pp. 9648-9653
-
-
Sugrue, M.M.1
Shin, D.Y.2
Lee, S.W.3
Aaronson, S.A.4
-
14
-
-
33646782954
-
P53 and disease: When the guardian angel fails
-
Royds JA and Iacopetta B: p53 and disease: when the guardian angel fails. Cell Death Differ 13: 1017-1026, 2006.
-
(2006)
Cell Death Differ
, vol.13
, pp. 1017-1026
-
-
Royds, J.A.1
Iacopetta, B.2
-
15
-
-
62649112876
-
A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53
-
Sur S, Pagliarini R, Bunz F, et al.: A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53. Proc Natl Acad Sci USA 106: 3964-3969, 2009.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 3964-3969
-
-
Sur, S.1
Pagliarini, R.2
Bunz, F.3
-
16
-
-
34248379012
-
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: Lessons from recent developments in the IARC TP53 database
-
DOI 10.1002/humu.20495
-
Petitjean A, Mathe E, Kato S, et al.: Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 28: 622-629, 2007. (Pubitemid 46744292)
-
(2007)
Human Mutation
, vol.28
, Issue.6
, pp. 622-629
-
-
Petitjean, A.1
Mathe, E.2
Kato, S.3
Ishioka, C.4
Tavtigian, S.V.5
Hainaut, P.6
Olivier, M.7
-
17
-
-
0027210981
-
Gain of function mutations in p53
-
DOI 10.1038/ng0593-42
-
Dittmer D, Pati S, Zambetti G, et al.: Gain of function mutations in p53. Nat Genet 4: 42-46, 1993. (Pubitemid 23165910)
-
(1993)
Nature Genetics
, vol.4
, Issue.1
, pp. 42-46
-
-
Dittmer, D.1
Pati, S.2
Zambetti, G.3
Chu, S.4
Teresky, A.K.5
Moore, M.6
Finlay, C.7
Levine, A.J.8
-
18
-
-
0028040742
-
Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness
-
Hsiao M, Low J, Dorn E, et al.: Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness. Am J Pathol 145: 702-714, 1994. (Pubitemid 24285977)
-
(1994)
American Journal of Pathology
, vol.145
, Issue.3
, pp. 702-714
-
-
Hsiao, M.1
Low, J.2
Dorn, E.3
Ku, D.4
Pattengale, P.5
Yeargin, J.6
Haas, M.7
-
19
-
-
60449106119
-
Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage
-
Liu Z, Liu Q, Xu B, et al.: Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage. Mutat Res 662: 75-83, 2009.
-
(2009)
Mutat Res
, vol.662
, pp. 75-83
-
-
Liu, Z.1
Liu, Q.2
Xu, B.3
-
20
-
-
67649438659
-
Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells
-
Choi MS, Oh JH, Kim SM, et al.: Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells. Int J Oncol 34: 1221-1230, 2009.
-
(2009)
Int J Oncol
, vol.34
, pp. 1221-1230
-
-
Choi, M.S.1
Oh, J.H.2
Kim, S.M.3
-
21
-
-
78649938412
-
Degradation of MDM2 by the interaction between berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells
-
Zhang X, Gu L, Li J, et al.: Degradation of MDM2 by the interaction between berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells. Cancer Res 70: 9895-9904, 2010.
-
(2010)
Cancer Res
, vol.70
, pp. 9895-9904
-
-
Zhang, X.1
Gu, L.2
Li, J.3
-
22
-
-
8844278362
-
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans
-
DOI 10.1016/j.cell.2004.11.022, PII S0092867404010517
-
Bond GL, Hu W, Bond EE, et al.: A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119: 591-602, 2004. (Pubitemid 39535748)
-
(2004)
Cell
, vol.119
, Issue.5
, pp. 591-602
-
-
Bond, G.L.1
Hu, W.2
Bond, E.E.3
Robins, H.4
Lutzker, S.G.5
Arva, N.C.6
Bargonetti, J.7
Bartel, F.8
Taubert, H.9
Wuerl, P.10
Onel, K.11
Yip, L.12
Hwang, S.-J.13
Strong, L.C.14
Lozano, G.15
Levine, A.J.16
-
23
-
-
39149132069
-
Berberine inhibits growth of the breast cancer cell lines MCF-7 and MDA-MB-231
-
DOI 10.1055/s-2007-993779
-
Kim JB, Lee KM, Ko E, et al.: Berberine inhibits growth of the breast cancer cell lines MCF-7 and MDA-MB-231. Planta Med 74: 39-42, 2008. (Pubitemid 351251381)
-
(2008)
Planta Medica
, vol.74
, Issue.1
, pp. 39-42
-
-
Jong, B.K.1
Lee, K.-M.2
Ko, E.3
Han, W.4
Jeong, E.L.5
Shin, I.6
Bae, J.-Y.7
Kim, S.8
Noh, D.-Y.9
-
24
-
-
0034731404
-
Phorbol ester-induced generation of reactive oxygen species is protein kinase Cbeta-dependent and required for SAPK activation
-
DOI 10.1074/jbc.M009322200
-
Datta R, Yoshinaga K, Kaneki M, Pandey P and Kufe D: Phorbol ester-induced generation of reactive oxygen species is protein kinase cbeta-dependent and required for SAPK activation. J Biol Chem 275: 41000-41003, 2000. (Pubitemid 32054926)
-
(2000)
Journal of Biological Chemistry
, vol.275
, Issue.52
, pp. 41000-41003
-
-
Datta, R.1
Yoshinaga, K.2
Kaneki, M.3
Pandey, P.4
Kufe, D.5
-
25
-
-
0032856186
-
TPA-enhanced motility and invasion in a highly metastatic variant (L-10) of human rectal adenocarcinoma cell line RCM-1: Selective role of PKC-alpha and its inhibition by a combination of PDBu-induced PKC downregulation and antisense oligonucleotides treatment
-
Shimao Y, Nabeshima K, Inoue T and Koono M: TPA-enhanced motility and invasion in a highly metastatic variant (L-10) of human rectal adenocarcinoma cell line RCM-1: selective role of PKC-alpha and its inhibition by a combination of PDBu-induced PKC downregulation and antisense oligonucleotides treatment. Clin Exp Metastasis 17: 351-360, 1999. (Pubitemid 29477581)
-
(1999)
Clinical and Experimental Metastasis
, vol.17
, Issue.4
, pp. 351-360
-
-
Shimao, Y.1
Nabeshima, K.2
Inoue, T.3
Koono, M.4
-
26
-
-
0345701256
-
Profile of gene expression induced by the tumour promotor TPA in murine epithelial cells
-
DOI 10.1002/ijc.11008
-
Schlingemann J, Hess J, Wrobel G, et al.: Profile of gene expression induced by the tumour promotor TPA in murine epithelial cells. Int J Cancer 104: 699-708, 2003. (Pubitemid 36418506)
-
(2003)
International Journal of Cancer
, vol.104
, Issue.6
, pp. 699-708
-
-
Schlingemann, J.1
Hess, J.2
Wrobel, G.3
Breitenbach, U.4
Gebhardt, C.5
Steinlein, P.6
Kramer, H.7
Furstenberger, G.8
Hahn, M.9
Angel, P.10
Lichter, P.11
-
27
-
-
1842482424
-
Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction
-
DOI 10.1038/sj.onc.1207307
-
Woo JH, Lim JH, Kim YH, et al.: Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene 23: 1845-1853, 2004. (Pubitemid 38445410)
-
(2004)
Oncogene
, vol.23
, Issue.10
, pp. 1845-1853
-
-
Woo, J.-H.1
Lim, J.H.2
Kim, Y.-H.3
Suh, S.-I.4
Min, D.S.5
Chang, J.-S.6
Lee, Y.H.7
Park, J.-W.8
Kwon, T.K.9
-
28
-
-
0038407256
-
Dykellic acid inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting nuclear factor kappa B transcriptional activity
-
Woo JH, Park JW, Lee SH, et al.: Dykellic acid inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting nuclear factor kappa B transcriptional activity. Cancer Res 63: 3430-3434, 2003.
-
(2003)
Cancer Res
, vol.63
, pp. 3430-3434
-
-
Woo, J.H.1
Park, J.W.2
Lee, S.H.3
-
29
-
-
0025271203
-
Association of human papillomavirus types 16 and 18 E6 proteins with p53
-
Werness BA, Levine AJ and Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76-79, 1990.
-
(1990)
Science
, vol.248
, pp. 76-79
-
-
Werness, B.A.1
Levine, A.J.2
Howley, P.M.3
-
30
-
-
0033519689
-
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136, 1990.31. Mantovani F and Banks L: Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines
-
Scheffner M, Werness BA, Huibregtse JM, Levine AJ and Howley PM: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136, 1990.31. Mantovani F and Banks L: Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines. Oncogene 18: 3309-3315, 1999.
-
(1999)
Oncogene
, vol.18
, pp. 3309-3315
-
-
Scheffner, M.1
Werness, B.A.2
Huibregtse, J.M.3
Levine, A.J.4
Howley, P.M.5
|